美国FDA生物制品紫皮书数据库
(U.S. FDA Purple Book: Database of Licensed Biological Products)
商品名 申请号 产品号 BLA类型 非专利名称 剂型 给药途径 规格/剂量 产品形式 批准日期 申请人 市场状态 许可证状态 参考产品非专利名称 参考产品专利名称
Omlyclo 761399 003 351(k) Interchangeable omalizumab-igec Injection Subcutaneous 300MG/2ML (150MG/ML) Pre-Filled Syringe 2025/12/01 CELLTRION, Inc. Rx Licensed omalizumab Xolair
Armlupeg 761212 001 351(k) Biosimilar pegfilgrastim-unne Injection Subcutaneous 6MG/0.6ML Pre-Filled Syringe 2025/11/28 Lupin Limited (Biotech Division) Rx Licensed pegfilgrastim Neulasta
Voyxact 761434 001 351(a) sibeprenlimab-szsi Injection Subcutaneous 400MG/2ML (200MG/ML) Pre-Filled Syringe 2025/11/25 Otsuka Pharmaceutical Company, Ltd. Rx Licensed N/A N/A
ITVISMA 125856 001 351(a) onasemnogene abeparvovec-brve Injection Intrathecal 4x10^13VG/ML Single-Dose Vial 2025/11/24 Novartis Gene Therapies, Inc. Rx Licensed N/A
Opdivo Qvantig 761381 002 351(a) nivolumab and hyaluronidase-nvhy Injection Subcutaneous 300MG/2.5ML;5,000UNITS/2.5ML (120MG/2,000UNITS/ML) Single-Dose Vial 2025/11/24 Bristol-Myers Squibb Company Rx Licensed N/A N/A
Poherdy 761450 001 351(k) Interchangeable pertuzumab-dpzb Injection Intravenous 420MG/14ML (30MG/ML) Single-Dose Vial 2025/11/13 Shanghai Henlius Biotech, Inc. Rx Licensed pertuzumab Perjeta
Osvyrti 761424 001 351(k) Interchangeable denosumab-desu Injection Subcutaneous 60MG/ML Pre-Filled Syringe 2025/10/29 Accord BioPharma Inc. Rx Licensed denosumab Prolia
Jubereq 761424 002 351(k) Interchangeable denosumab-desu Injection Subcutaneous 120MG/1.7ML (70MG/ML) Single-Dose Vial 2025/10/29 Accord BioPharma Inc. Rx Licensed denosumab Xgeva
Blenrep 761440 001 351(a) belantamab mafodotin-blmf For Injection Intravenous 70MG Single-Dose Vial 2025/10/23 GlaxoSmithKline LLC Rx Licensed N/A N/A
Eydenzelt 761377 001 351(k) Biosimilar aflibercept-boav Injection Intravitreal 2MG/0.05ML Single-Dose Vial 2025/10/02 CELLTRION, Inc. Rx Licensed aflibercept Eylea
Eydenzelt 761377 002 351(k) Biosimilar aflibercept-boav Injection Intravitreal 2MG/0.05ML Pre-Filled Syringe 2025/10/02 CELLTRION, Inc. Rx Licensed aflibercept Eylea
QIVIGY 125822 001 351(a) Immune Globulin Intravenous, Human-kthm, 10% Solution Solution Intravenous 5G/50ML Single-Dose Vial 2025/09/26 Kedrion, S.p.A. Rx Licensed N/A
QIVIGY 125822 002 351(a) Immune Globulin Intravenous, Human-kthm, 10% Solution Solution Intravenous 10G/100ML Single-Dose Vial 2025/09/26 Kedrion, S.p.A. Rx Licensed N/A
Enoby 761439 001 351(k) Interchangeable denosumab-qbde Injection Subcutaneous 60MG/ML Pre-Filled Syringe 2025/09/26 Hikma Pharmaceuticals USA Inc. Rx Licensed denosumab Prolia
Xtrenbo 761439 002 351(k) Interchangeable denosumab-qbde Injection Subcutaneous 120MG/1.7ML (70MG/ML) Single-Dose Vial 2025/09/26 Hikma Pharmaceuticals USA Inc. Rx Licensed denosumab Xgeva
Keytruda Qlex 761467 001 351(a) pembrolizumab and berahyaluronidase alfa-pmph Injection Subcutaneous 395MG/2.4ML; 4,800UNITS/2.4ML (165MG/2,000UNITS/ML) Single-Dose Vial 2025/09/19 Merck Sharp & Dohme LLC Rx Licensed N/A N/A
Keytruda Qlex 761467 002 351(a) pembrolizumab and berahyaluronidase alfa-pmph Injection Subcutaneous 790MG/4.8ML; 9,600UNITS/4.8ML (165MG/2,000UNITS/ML) Single-Dose Vial 2025/09/19 Merck Sharp & Dohme LLC Rx Licensed N/A N/A
Bosaya 761436 001 351(k) Interchangeable denosumab-kyqq Injection Subcutaneous 60MG/ML Pre-Filled Syringe 2025/09/16 Biocon Biologics Inc. Rx Licensed denosumab Prolia
Aukelso 761436 002 351(k) Interchangeable denosumab-kyqq Injection Subcutaneous 120MG/1.7ML (70MG/ML) Single-Dose Vial 2025/09/16 Biocon Biologics Inc. Rx Licensed denosumab Xgeva
Skyrizi 761105 007 351(a) risankizumab-rzaa Injection Subcutaneous 180MG/1.2ML (150MG/ML) Pre-Filled Syringe 2025/09/03 AbbVie Inc. Rx Licensed N/A N/A
当前数据更新日期:2026年04月12日,更多信息请点击此处查询美国FDA药品数据库

数据库说明:

©2006-2026 DrugFuture->U.S. FDA Purple Book